This study's aim is to evaluate the feasibility of introducing a women's malignancy survivorship clinic incorporating symptom management through ePRO collection (complex intervention) into routine follow up care in patients with early-stage Hormone Receptor(HR)-positive breast and gynaecologic cancer post primary curative therapy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of patients enrolled in the clinic.
Timeframe: At the baseline
Reasons for not enrolling to the study.
Timeframe: At the baseline
Reasons for not completing the intervention (drop out).
Timeframe: During the study period (12-month)
Percentage of adherence to the intervention completing ePROs surveys
Timeframe: Baseline, each 2 months till end intervention (12 months)
Number of patients who partake in healthcare professional consultations after ePRO data triggers.
Timeframe: Baseline, each 2 months till end intervention (12 months)
Average consultation time in the Womens Survivorship Clinic.
Timeframe: Baseline, each 2 months till end intervention (12 months)